Patients have voices. And they’re making themselves heard. Better informed and aware than ever before, thanks to online websites, forums and research libraries, the empowered patient has become a formidable force to be reckoned with. The question is: how is pharma responding?
Increasingly, the answer has been patient-centric departments within organisations, who have launched everything from awareness/education campaigns and apps to patient support programmes across multiple platforms. Yet, to date, such programs lack the deep background needed to truly access patient input. What’s more, there is no broad consensus on patient-centric practices, nor are there standard operating procedures. That is, until now.
In Patient-Centricity: Solving the latest marketing puzzle, FirstWord gathers the collected wisdom and shared intelligence of industry experts currently engaged in patient affairs. Over six parts, the report explores the myriad unknowns of patient empowerment and provides a critical overview that aims to establish a broad consensus, best practices and insight into how to integrate patient-centricity into the pharma business model.
Patient-Centricity: Solving the latest pharma puzzle answers key questions:
Patient-centric efforts are moving to the forefront of pharmas interests. In this report, you will discover:
Key Report Features
Over the past five years, patient empowerment has become one of the most actively discussed topics in pharma marketing. Yet the experience and efforts of organisations attempting to create cohesive patient-centric programmes have not lead to any clear road map for the industry. Patient-Centricity: Solving the latest pharma puzzle offers a clear-eyed analysis of the current state of patient-centricity and a guide for creating consensus. Amongst the benefits, this report will help you to:
Selected quotes from the report
“My dream scenario is that every part of the company on their own headcount, on their own resources, appoints a patient champion with whom we can then connect and share as a true network. He or she doesn’t need to report to me. There’s absolutely no reason to. It’s a true matrix.” Dr Lode Dewulf, chief patient affairs officer, UCB
“The insights that we have already gained and will continue to gain allow us to push those insights into R&D to come up with potentially better solutions at the onset. We have a better picture of what patients want from us and expect from us. That allows our R&D staff to think about the patient much earlier on in development and ultimately will lead to a much better solution for patients in the long run.” John Koconis, president and CEO, LEO Pharma Inc.
“One of the big issues with patient-centricity is that there is a lot of feedback and a lot of things coming back, but who’s looking at them? And who is in the decision-making role responsible for this? Very often in big companies, you don’t find that role.” Ashok Bhaseen, vice-president of marketing and sales, Pediapharm
Table of Contents
for Patient-Centricity: Solving the latest pharma puzzle
2.Part One: The patient mandate
2.1.An altered landscape
2.2.Playing in a patient-centred ecosystem
2.4.The state of patient-centricity in Pharma
2.5.The trial and error phase
2.5.1.The burden of ROI
2.6.Persistence at a premium
3.Part Two: Establishing a permanent infrastructure for patient-centricity
3.1.Par for the course
3.2.Elevating above brand
3.3.Selecting an above-brand structure
3.3.1.UCB patient affairs
3.3.2.LEO Pharma: PRISM
3.4.Don’t be a dictator
3.5.Create internal platforms
3.6.A graduated understanding of ROI
4.Part Three: Creating patient-centric drugs
4.1.Leveraging internal resources to identify patient need
4.1.2.R&D and marketing
4.1.3.R&D and PAPs
4.2.Learning from patients and patient groups
4.3.Thyroid Federation Internationa
4.3.1.Best practice one: Don’t try to ingratiate yourself
4.3.2.Best practice two: Keep the patient’s interest in mind at all times
4.4.The National Psoriasis Foundation
4.5.Post-learning design phase
4.6.Benefits of embracing patient-centricity early on
5.Part Four: Defining the patient journey
5.1.Conduct primary research that counts
5.1.2.Traditional focus groups
5.2.1.Attend the market research
5.2.2.Follow the insights
5.2.3.Don’t reduce everything to a matter of cost or side effects
6.Part Five: Launching patient-centric marketing campaigns
6.1.Comprehensive, not all-consuming
6.2.Tailored, not one-size-fits-all
6.2.1.Focal segmental glomerulosclerosis
6.3.Apply a cultural filter
6.4.Keep it simple
6.5.Distribute via the community
6.6.Trial and error
7.Part Six: Conclusion (an open-book approach)
7.1.Five stages of patient-centricity adoption
8.Conclusion and best practice
Number of Pages
|Title||Date Published||Price from||More Details|
|Patient Centric Pharma: Restructuring business for better outcomes|
IntroductionIs “patient centricity” a passing fad? Experts say it’s here to stay. In fact, it’s been...
|01 Aug 2015 by FirstWord Pharma||USD $695||More Info|
|Patient-Centric Mobile Apps: Key Opportunities and Challenges for Pharma|
IntroductionDozens of new health apps for smartphones and tablets are produced monthly. Hundreds of ...
|01 Jul 2015 by FirstWord Pharma||USD $695||More Info|
|Harnessing the Power of Patient Support Programmes: pharma, patient and payer perspectives|
IntroductionIt all started years ago, with a few patients asking questions on the internet. These da...
|01 Apr 2015 by FirstWord Pharma||USD $695||More Info|
|Trends and Innovations in Patient Adherence|
IntroductionTaking the right dose of the right medicine at the right time is key to improving health...
|01 Mar 2015 by FirstWord Pharma||USD $695||More Info|
|Patient Assistance Programs: Payer and Pharma Perspectives|
IntroductionPatient assistance programs (PAPs) are evolving in response to increasingly restrictive ...
|02 Oct 2014 by FirstWord Pharma||USD $695||More Info|
|Pharma-Patient Engagement: insights from patient opinion leaders|
IntroductionTPatients and Pharma want the same thing, but for different reasons. Patients want acces...
|20 Jun 2014 by FirstWord Pharma||USD $695||More Info|
|Physician Views - Breathing new life into patient care; patient-centric services in the respiratory market|
Scope According to the Institute of Medicine, patient-centric care can be defined as "providing care...
|08 Apr 2014 by FirstWord Pharma||USD $695||More Info|
|The Impact of Mobile Health on Patient-Centric Disease Management|
IntroductionBanks use them. So does the travel industry. And tastemakers are harnessing their power ...
|01 Aug 2013 by FirstWord Pharma||USD $695||More Info|
|New Thinking in Patient Adherence|
IntroductionPatient non-adherence is estimated to represent 0 billion per year in avoidable medic...
|01 Mar 2012 by FirstWord Pharma||USD $695||More Info|
|Generic Defence Strategies: Targeting Patient Co-Pay|
IntroductionCoupons for co-pays are fast becoming a standard part of the brand marketer’s toolkit, d...
|01 Mar 2012 by FirstWord Pharma||USD $695||More Info|
This report is published by FirstWord Pharma
Download Free Report Summary PDF
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Accepted Card Types
Buy now using our secure payment system.